These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 16504306

  • 1. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE, Raidal SL, Pecenpetelovska G, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):97-108. PubMed ID: 16504306
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM, Fischer L, Baudu P, Guigal PM, Sindle T, Mumford JA, Audonnet JC.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):47-57. PubMed ID: 16580075
    [Abstract] [Full Text] [Related]

  • 5. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G, Hussey SB, Whalley JM, Allen GP, Koen MT, Santucci N, Fraser DG, Macklin MD, Swain WF, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):81-95. PubMed ID: 16549215
    [Abstract] [Full Text] [Related]

  • 6. Temporal detection of equine herpesvirus infections of a cohort of mares and their foals.
    Bell SA, Balasuriya UB, Gardner IA, Barry PA, Wilson WD, Ferraro GL, MacLachlan NJ.
    Vet Microbiol; 2006 Sep 10; 116(4):249-57. PubMed ID: 16774810
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection.
    Patel JR, Didlick S, Bateman H.
    Equine Vet J; 2004 Jul 10; 36(5):447-51. PubMed ID: 15253088
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
    Matsumura T, Kondo T, Sugita S, Damiani AM, O'Callaghan DJ, Imagawa H.
    Virology; 1998 Mar 01; 242(1):68-79. PubMed ID: 9501037
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
    Schnabel CL, Babasyan S, Rollins A, Freer H, Wimer CL, Perkins GA, Raza F, Osterrieder N, Wagner B.
    J Virol; 2019 Nov 15; 93(22):. PubMed ID: 31462575
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.
    Perkins G, Babasyan S, Stout AE, Freer H, Rollins A, Wimer CL, Wagner B.
    Virology; 2019 May 15; 531():219-232. PubMed ID: 30928700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.